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ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) is a global human health problem causing infections in both hos-
pitals and the community. Companion animals, such as cats, dogs, and horses, are also frequently colonized byMRSA and can
become infected. We sequenced the genomes of 46 multilocus sequence type (ST) 22MRSA isolates from cats and dogs in the
United Kingdom and compared these to an extensive population framework of human isolates from the same lineage. Phylog-
enomic analyses showed that all companion animal isolates were interspersed throughout the epidemic MRSA-15 (EMRSA-15)
pandemic clade and clustered with human isolates from the United Kingdom, with human isolates basal to those from compan-
ion animals, suggesting a human source for isolates infecting companion animals. A number of isolates from the same veterinary
hospital clustered together, suggesting that as in human hospitals, EMRSA-15 isolates are readily transmitted in the veterinary
hospital setting. Genome-wide association analysis did not identify any host-specific single nucleotide polymorphisms (SNPs) or
virulence factors. However, isolates from companion animals were significantly less likely to harbor a plasmid encoding erythro-
mycin resistance. When this plasmid was present in animal-associated isolates, it was more likely to contain mutations mediat-
ing resistance to clindamycin. This finding is consistent with the low levels of erythromycin and high levels of clindamycin used
in veterinary medicine in the United Kingdom. This study furthers the “one health” view of infectious diseases that the pathogen
pool of human and animal populations are intrinsically linked and provides evidence that antibiotic usage in animal medicine is
shaping the population of a major human pathogen.
IMPORTANCE Methicillin-resistant Staphylococcus aureus (MRSA) is major problem in human medicine. Companion animals,
such as cats, dogs, and horses, can also become colonized and infected byMRSA. Here, we demonstrate that a shared population
of an important and globally disseminated lineage of MRSA can infect both humans and companion animals without undergo-
ing host adaptation. This suggests that companion animals might act as a reservoir for human infections. We also show that the
isolates from companion animals have differences in the presence of certain antibiotic resistance genes. This study furthers the
“one health” view of infectious diseases by demonstrating that the pool of MRSA isolates in the human and animal populations
are shared and highlights how different antibiotic usage patterns between human and veterinary medicine can shape the popula-
tion of bacterial pathogens.
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Staphylococcus aureus is part of the natural microbiota of hu-mans and animals but has the potential to cause a broad spec-
trum of infections. The emergence and spread of methicillin-
resistant S. aureus (MRSA) in both hospital and community
settings pose a major threat to global health. Since the initial de-
scription in 1961, MRSA has spread globally with a small number
of specific clones, including multilocus sequence types 239
(ST239), ST22, and ST8, causing the majority of the burden of
disease (1, 2). Since the late 1990s, the role that both livestock and
companion animals play as reservoirs and vectors for transmis-
sion of MRSA has become clearer (3–5). This relationship seems
to be bidirectional, with humanorigins for the ST5 poultry lineage
(6) and clonal complex 398 (CC398) originally infecting humans,
jumping to livestock, and then back to humans (7, 8). More re-
cently a number of “multihost”MRSA lineages with a novelmecA
gene homologue, namedmecC, were identified, which are capable
of colonizing and infecting a broad range ofmammalian and avian
species (9–11). Companion animals, such as cats, dogs, and
horses, are also frequently colonized by MRSA and can become
infected (11–13). In dogs, reported MRSA carriage rates range
from 0.7% in Portugal (14), to 2.3 to 9% in the United Kingdom
(15, 16), and up to 20% in an outbreak in Canada (17). The prev-
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alence of MRSA colonization of cats appears to be lower than that
for dogs, with reported carriage rates of 0 to 4% (18), including
1.4% in Portugal (14) and 1.48% in the United Kingdom (13).
Risk factors for MRSA infection in companion animals include
contact with human MRSA carriers, the number of courses of
antimicrobials received, length of time spent in veterinary clinics,
and use of surgical implants (12, 15).MRSA lineages isolated from
companion animals generally match the dominant lineages found
in the human populations in the same geographical area: ST22
(epidemic MRSA 15 [EMRSA-15]) in the United Kingdom (19),
Germany (20, 21), Portugal (22), and ST59/ST239 in China (23,
24). Molecular epidemiology using pulsed-field gel electrophore-
sis (PFGE) and spa typing has found that human and companion
isolates are indistinguishable, suggesting transmission between
humans and companion animals (25–29). Furthermore, a small
number of studies have identified companion animals as the likely
source for human MRSA infections (3, 28, 30). In the United
Kingdom, ST22 (EMRSA-15) makes up the bulk of hospital-
acquired cases of MRSA (31). A recent detailed phylogenomic
study of the ST22 lineage demonstrated that it is likely to have
emerged in the United Kingdom in the 1980s and then spread
globally, with its initial success probably driven by the acquisition
of fluoroquinolone resistance at a time of increasing fluoroquin-
olone usage (32). A single-locus variant of ST22 (ST2371) with
Pantón-Valentine leukocidin (PVL) was recently tracked using
whole-genome sequencing as spreading from a hospital outbreak
into the community, demonstrating the highly transmissible na-
ture of this clone (33). In this study, we sequenced the genomes of
46 isolates from companion animals (4 feline and 42 canine) from
a collection of ST22 MRSA isolates from the United Kingdom
isolated between 2003 and 2007. We compared these isolates to
the recently published ST22 phylogeny (32) in order to under-
stand the phylogenetic relationship between isolates infecting hu-
mans and companion animals. This showed that a shared popu-
lation of ST22 isolates infects humans and companion animals.
This study confirms the extended host spectrum of ST22 isolates,
which is potentially a key factor contributing to the success of this
lineage.
RESULTS
Phylogenetics of companion animal isolates in comparison to
human isolates.To investigate the relationship between ST22 iso-
lates from companion animals and humans, we sequenced the
genomes of 46 ST22 isolates from companion animals (42 canine
and 4 feline) isolated between August 2003 and August 2007 (see
Table S1 in the supplemental material). The isolates were from
two large veterinary hospitals (TheRoyal VeterinaryCollege,Her-
efordshire, United Kingdom [24 isolates] and The Animal Health
Trust, Suffolk, United Kingdom [5 isolates]), and a number of
smaller veterinary practices throughout the United Kingdom (17
isolates). The companion animal isolates were from infections
similar to those associatedwith ST22 in humans, with themajority
of isolates coming from wound infections (including surgical site
infections) (21) or skin and soft tissue infection (SSTI) (7). The
collection also included isolates from urine (4), cerebrospinal
fluid (CSF) (2), and nasal wash or discharge (2), and one isolate
each from a bloodstream, heart valve, and joint infection. Only
one isolate was fromnasal carriage, and for six isolates, the clinical
source was unknown. An additional 22 human CC22 isolates se-
quenced as part of other studies were also included in the analysis
(34). The sequences were mapped against the ST22 reference ge-
nome HO 5096 0412 and then combined with the ST22 isolates
previously reported by Holden et al. (32). Single nucleotide poly-
morphisms (SNPs) in the core genome were then used to recon-
struct the phylogenetic relationships between the isolates. The
substitution rate across the core genome under a constant popu-
lation size model was estimated as 1.47 106 per nucleotide site
per year (95% Bayesian credible interval, 1.34  106 to 1.60 
106), and for an exponentially growing population, it was esti-
mated as 1.48  106 (95% Bayesian credible interval, 1.36 
106 to 1.60 106), similar to that previously reported for ST22
(32). No statistically significant difference was seen between the
substitution rates for companion animal and human isolates
(Fig. 1). Analysis of the phylogeny revealed that all of the compan-
ion animal isolates belonged to the previously described epidemic
MRSA 15 (EMRSA-15) pandemic clade (ST22-A2 in reference 32)
FIG 1 Rates of evolution on the terminal branches of the dated phylogeny. Points representmedian estimates, and lines represent 95% highest posterior density
(HPD) estimates of substitution rate (substitutions per site per year) for each terminal branch in a maximum clade consensus tree. Branches are colored by the
host state associated with that branch: red for cats, green for dogs, and cyan for humans.
Harrison et al.
2 ® mbio.asm.org May/June 2014 Volume 5 Issue 3 e00985-13
 
m
bio.asm
.org
 o
n
 July 15, 2014 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
(Fig. 2A). The companion animal isolates were broadly distrib-
uted throughout the EMRSA-15 pandemic clade and, with one or
two exceptions, clustered together with human isolates in United
Kingdom-specific clades (Fig. 2A and 3). In all cases, human iso-
lates were basal to those from companion animals, indicating that
the evolutionary origin of the companion animal isolates was
likely to be human. One particularly large clade of isolates con-
tained human, cat, and dog isolates from three different veterinary
practices in London and the southeast of England (see isolates in
and around clades 1, 3, and 5 in Fig. 2A and 3).
Isolates from large veterinary hospitals cluster together. In
general, the isolates from the larger veterinary hospitals clustered
FIG 2 Phylogenetic relationships between human and companion animal isolates. (A) A maximum likelihood tree generated from SNPs in the core genome is
shown. The tree is rooted in isolate IRL_Ireland_1993 as an outgroup (previously identified as basal to the EMRSA-15 clade by Holden et al. [32]). Isolates and
branchesmarked in red, blue, and black are fromdogs, cats, and humans, respectively. Closely related isolates from the Royal VeterinaryHospital, Hertfordshire,
United Kingdom, with available temporal information are highlighted and numbered based on date of isolation. (B) Time line of isolates in the Royal Veterinary
Hospital, Hertfordshire, United Kingdom. Individual marks denote an isolate. Numbering denotes clades highlighted in the phylogeny.
EMRSA-15 Isolates in Humans and Companion Animals
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together on the phylogenetic tree, while those from individual
veterinary practices were not clustered with other companion an-
imal isolates (see isolates from the Royal Veterinary College
[RVC]) (isolates labeled “Hertfordshire” in Fig. 2A) and from the
AnimalHealth Trust (AHT) (isolates labeled “Suffolk” in Fig. 2A).
This was confirmed by randomization tests for significant cluster-
ing on the tree (isolates from large hospitals, P  0.011; isolates
from individual veterinary practices, P 0.929). The RVC is sit-
uated in the southeast of England just outside London, and the
majority of the isolates from the RVC (16 of 24 isolates) were also
part of the large clade (described above) containing both human
and companion animal isolates from London and the southeast
(see isolates in and around clades 1, 3, and 5 in Fig. 2A). The
phylogeny suggests that the RVC isolates were drawn from a pop-
ulation of EMRSA-15 isolates thatwas circulatingwidely through-
out the human population of London and the southeast. Further
analysis, focusing on isolates from the RVC, showed that multiple
distinct clades with two or more closely related isolates separated
by a small number of SNPs were circulating in the RVC between
November 2003 and August 2006 (clades 1 to 5 in Fig. 2A). In two
cases, in clades 2 and 3, three closely related isolates from different
animals were isolatedwithin ~2months of each other (Fig. 2A and
B), while isolates from clades 1, 4, and 5 were isolated from ani-
mals over a longer time periods (~6 to 12 months) (Fig. 2B).
Within each clade, isolates from a range of infections were
present, demonstrating the ability of highly related isolates to
cause a broad spectrum of disease in companion animals, as is the
case in humans. In addition to the clusters of related isolates, a
number of individual phylogenetically distinct isolates were also
associated with infections in the RVC throughout the same period
(Fig. 2A and B). A similar picture was seen in isolates from the
other veterinary hospital in the study, the AHT, where two clades
of closely related isolates were identified (isolates GBR_Suf-
folk_2005/a and GBR_Sufflok_2007/b in Fig. 2A). Phylogenetic
analysis also identified a case of chronic infection or reinfection.
Two wound isolates from the same cat taken ~20 days apart
(GBR_Glasgow_2006 and GBR_Glasgow_2006a in Fig. 2), dif-
fered by only 3 SNPs, indicating that they shared a recent common
ancestor. The level of diversity in these isolates is well within the
observed variation of isolates in known cases of EMRSA-15 trans-
mission (35), suggesting either a chronic wound infection or re-
infection from the same source (Fig. 2A). Unfortunately, there
was no further clinical information available to investigate the
epidemiology.
Comparison of virulence factors and antibiotic resistance
genesbetweenhumanandanimal isolates. Inorder to investigate
if there was a genetic basis for the ability to colonize and cause
disease in different hosts, we performed comparative genomic
analysis on the ST22 isolates from the companion animals and
human ST22 isolates. The entire collection of companion animal
isolates was genotypically MRSA and harbored the SCCmec type
IVh element as seen in the human ST22 isolates (32). All of the
companion animal isolates had both of the fluoroquinolone resis-
tance mutations in Ser80Phe in GrlA and Ser84Leu in GyrA pre-
viously described in human ST22 isolates (32). We assessed if the
animal and human isolates shared the same virulence factors and
antibiotic resistance genes previously identified in the human iso-
lates (see Table S1 in the supplemental material) (32). We identi-
fied that the companion animal isolates were statistically more
likely to have lost both the Sa3 phage (containing the human-
specific immune evasion genes sak, chips, and scin), with 76.1%
Sa3 positive, cf. 90.2% (Fisher’s exact test, P  0.022), and the
plasmid borne erm(C) erythromycin resistance gene, with 37%
erm(C) positive, cf. 62% (Fisher’s exact test, P  0.002) (Fig. 3).
These analyses treat each isolate as an independent observation
and so neglect the evolutionary history of the isolates as revealed
by phylogenetic analysis. To control for phylogenetic noninde-
pendence, we treated the host state (human versus companion
animal) and the presence of the Sa3 phage (present versus ab-
sent) as binary traits and tested whether these traits evolved across
the phylogeny in a correlated fashion. The results showed that a
model with correlated evolution was not preferred to a model in
which the traits evolved independently (Bayes factor 1, Bayes-
Traits [73]), suggesting that companion animal isolates were no
less likely to lose the Sa3 phage than would be expected by
chance. However, when we applied the same test to erm(C), cor-
related evolution between host state and loss/gain of erm(C) had
substantial support (Bayes factor 9), providing further evidence
that loss of erm(C) was associated with isolates coming from com-
panion animals rather than humans. This host-species-associated
loss is clearly visible on the phylogenetic tree, with the clades of
companion animal isolates having lost the ErmC-encoding plas-
mid, while closely related and basal human isolates retained this
plasmid (Fig. 3). We also identified three feline isolates
(GBR_Glasgow_2006a, GBR_Glasgow_2006b, and GBR_Essex_
2006) with genetic rearrangements disrupting the regulatory re-
gion upstream of erm(C), rendering its expression constitutive
and thereby conferring resistance to clindamycin (36). Resistance
to clindamycin in all three isolates was confirmed by phenotypic
testing. Interestingly, the clindamycin-resistant isolates included
the two isolates from the same cat described previously
(GBR_Glasgow_2006a and GBR_Glasgow_2006b) that only dif-
fer by 3 SNPs. Furthermore, these two isolates each had different
genetic rearrangements in the leader peptide, suggesting that two
separate events led to resistance to clindamycin in these closely
related isolates. The chronologically first isolate from the cat
(GBR_Glasgow_2006) had an insertion (IS) element inserted in
the leader peptide, 66 bp upstream of the erm(C) start codon,
while the second isolate, isolated ~20 days later, had a 58-bp de-
letion of the leader peptide, 69 bp upstream of the erm(C) start
codon, (GBR_ Glasgow_2006a). The third isolate, also from a cat
(GBR_Essex_2006), contained an insertion of an IS element in the
leader peptide region, 67 bp upstream of the start codon of
erm(C). In contrast, none of 22 human isolates from the United
Kingdom included in this study had the same or functionally
equivalent rearrangements, as had been reported previously by
Holden et al. (32) for the rest of United Kingdom human ST22
isolates and as found also in a wider study of the United Kingdom
population of ST22 isolates (S. Peacock, personal communica-
tion).
No evidence of adaption to companion animals. To further
identify if the isolates infecting the companion animals had mu-
tations that might be associated with host adaptation, we used a
genome-wide association (GWAS) approach. This approach uses
multivariate regression analysis to identify SNPs in the core ge-
nome that are significantly associated with host state (e.g., SNPs
present or absent in companion animal versus human isolates).
The analysis showed very little genetic discrimination between
isolates from different hosts (see Fig. S2 in the supplemental ma-
terial), suggesting that the ST22 isolates had not undergone exten-
Harrison et al.
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sive adaptation to companion animals. Five SNPs (three nonsyn-
onymous, two synonymous) showed a more marked correlation
with host state (companion animals) (see Fig. S3 and Table S3 in
the supplemental material). However, ancestral state reconstruc-
tion of these SNPs across the phylogeny identified that they had
each arisen only once in a single clade with both companion ani-
mal isolates and human isolates (Fig. 1 and 3, isolates around
clades 1, 3 and 4). In addition, they had not been lost in human
isolates from this clade (Fig. 2A). As such, it is most parsimonious
to assume that the population structure alone was responsible for
this correlation. Therefore, using this approach we were unable to
identify any homoplasic SNPs potentially involved in host adap-
tion to the companion animals.We also investigated pseudogenes
present in the ST22 isolates in an attempt to identify any particular
gene inactivations that might be associated with adaption to com-
panion animals. However, we were unable to find any pseudo-
genes that had arisen more than once in companion animal iso-
lates when taking into account the population structure (data not
shown).
DISCUSSION
This is the first high-resolution genomic study of companion an-
imalMRSA isolates, confirmingwhat has been previously inferred
from epidemiological data and lower-resolution molecular tech-
niques (multilocus sequence typing [MLST], spa, and PFGE typ-
ing) that humans and companion animals readily exchange and
share the MRSA isolates from the same population (16, 21, 25).
Beyond this, we identified geographical structuring of human and
FIG 3 Presence and absence ofSa3 phage (sak, chips, and scn) and erm(C) in isolates in the ST22 phylogeny. Figure shows amaximum likelihood tree generated
from SNPs in the core genome, the tree is rooted in isolate IRL_Ireland_1993 as an outgroup. Isolates marked in red, blue, and black are from dogs, cats, and
humans, respectively. Branches and clades of isolates from the United Kingdom are marked in orange. The presence and absence of Sa3 phage and erm(C) are
indicated by the green and purple dots, respectively.
EMRSA-15 Isolates in Humans and Companion Animals
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companion animal isolates from London and southeast England,
suggesting that the same lineage was being exchanged between
humans and companion animals in the local population. The
widespread distribution of companion animal isolates through-
out the EMRSA-15 phylogeny demonstrates that in all likelihood
most EMRSA-15 isolates are capable of infecting both humans
and companion animals. This ability to infect different hosts has
been suggested to be an “extended-spectrum genotype” (20). A
similar ability to cause infections in multiple species with limited
genomic variation between strains has also been reported for
ST130 (37) and CC398 (7). Speculatively, this ability to colonize
and infect multiple species might be a beneficial adaption that
provides EMRSA-15 isolates with an alternative pathway for
transmission between human populations and that has contrib-
uted to the success of EMRSA-15, which is now the dominant
lineage in much of Europe (38). Additionally, ST8 (USA300), the
dominant lineage in North America, has been identified in cattle
in Switzerland (39), cats and dogs in France (40), and cats, dogs,
and pigs in theUnited States (41) and has been shown to be able to
bind porcine corneocytes and persist in the nasal cavity of pigs
(42). This suggests that a broad host range might be a common
feature of successful S. aureus lineages and be characteristic of
their long-term evolutionary history. Alternatively this might
simply be due to a founder effect and simply reflect the predomi-
nant clones circulating in a particular geographical area.
We identified that, in a number of cases, isolates from the same
veterinary hospitals clustered together, and highly related isolates
were present in the same veterinary hospital over extended peri-
ods of time (~6 to 12 months). This suggests that EMRSA-15
isolates were persisting and being readily transmitted within the
veterinary hospitals, as has been observed in human hospitals,
suggesting that the pandemic potential of this clone is greater than
generally acknowledged (33, 43). This finding is also consistent
with the fact that all of the companion animal isolates in this study
were from the predominately hospital-acquired EMRSA-15
(ST22-A) sublineage identified by Holden et al. rather than the
predominately community-acquired broader ST22 group (32).
The transmissibility of a hospital-acquired MRSA clone in a vet-
erinary hospital setting demonstrates thatMRSAprevention prac-
tices used in humanmedicine, such as search and destroy or blan-
ket decolonization, may also be appropriate in veterinary practice
(44). Further studies using whole-genome sequencing to investi-
gate temporally paired human and companion isolates from vet-
erinary hospitals and the human community are warranted to
further understand the exact transmission dynamics between hu-
mans and companion animals.
A number of studies have identified genetic changes associated
with adaptation of S. aureus to new host species (6, 7), including
the most recent study of CC97 isolates jumping from cattle into
humans (45). A common theme among these studies is the acqui-
sition or loss of the -toxin-converting phage (Sa3), which en-
codes the modulators of the human innate immune response;
staphylokinase (SAK), staphylococcal complement inhibitor
(SCIN), and chemotaxis inhibitory protein of S. aureus (CHIPS).
We found no significant difference in the presence or absence of
the Sa3 phage between human and companion animal isolates
when correcting for shared evolutionary history. This lack of dif-
ference in the presence of Sa3 might be expected. While both
CHIPS and SCIN are human specific and have significantly re-
duced activity against canine serum and neutrophils, respectively,
SAK has been demonstrated to enhance the activation of canine
plasminogen activation in vitro, suggesting that itmight play a role
in canine infections (46–48). No further loss or gain of virulence
factors was associated with the isolates infecting companion ani-
mals, nor were any particular mutations (SNPs) detected in the
core genomeby aGWAS approach. This leads us to the conclusion
that the core EMRSA-15 genome, present in isolates throughout
the EMRSA-15 phylogeny, is sufficient to confer isolates with an
extended host spectrum. EMRSA-15 has also been isolated from
horses in Germany, United Kingdom, and Ireland (49, 50), goats
in Spain (51), and a broad range of animal species, including a
rabbit, parrot, turtle, and bat in Germany (52). Further studies
including these isolates are needed to investigate if the same is true
for isolates from diverse animal species.
One particularly interesting finding was that the companion
animal isolates were significantly less likely to havemaintained the
plasmid-carried erm(C) gene, suggesting that the selective pres-
sures for maintenance of the erm(C) plasmid are less in compan-
ion animals or that erm(C) is selected against. Previously,Harris et
al. (33) reported the loss of the erm(C) plasmid in the CC22 iso-
lates from two patients and in 18 of 20 colonies sequenced from a
single colonized individual, suggesting this might be relatively
common occurrence in the absence of selection (33, 53), as has
been reported for other plasmids (54). Antibiotic resistance itself
can comewith significant fitness costs that can exact selective pres-
sure elsewhere in the genome (55–57). In the United Kingdom,
the use of erythromycin is rare in small animal veterinary medi-
cine. During the period when the isolates in this study were col-
lected (2005 to 2007), no erythromycin authorized for use in com-
panion animals was sold in theUnitedKingdom (58–60). Another
study by Mateus et al. in 2007 of 11 United Kingdom veterinary
practices found that erythromycin usage was very rare and made
up only 0.16% and 0.08% of prescriptions in dogs and cats, re-
spectively (61). The picture in human medicine is dramatically
different: 6.04 million prescriptions for erythromycin were made
by general practitioners (GPs) between April 2005 and March
2007 in England alone (62). Thus, it is likely that the lack of usage
of erythromycin in veterinary medicine in the United Kingdom
meant there was a lack of selective pressure for themaintenance of
erm(C) in companion animal isolates.
We also identified that three of the feline isolates had separate
genetic rearrangements in the erm(C) leader peptide that are as-
sociated with the generation of clindamycin resistance. Previ-
ously, Holden et al. (32) suggested that the lack of clindamycin
resistance in United Kingdom isolates from humans in compari-
son to isolates from other countries, including Germany and Swe-
den, was due tomuch higher clindamycin usage in these countries
than in the United Kingdom. While there is very little use of lin-
cosamides (of which clindamycin is a member) in human medi-
cine in the United Kingdom (63), clindamycin is used widely in
veterinary practice in theUnitedKingdom (61). A total of 2,533 kg
of clindamycin authorized for use in companion animals was sold
between 2005 and 2007 (58–60). Although clindamycin resistance
was only present in three companion animal isolates, the fact that
we identified two highly related isolates with different kinds of
genetic rearrangements (IS insertion anddeletion) combinedwith
the significantly higher usage of clindamycin in veterinary practice
does suggest that there might be a greater selective pressure for
clindamycin resistance in veterinary settings as opposed to human
health care settings.
Harrison et al.
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We conclude that the intermingling of human and companion
animals isolates within the EMRSA-15 pandemic clade suggests
that isolates were capable ofmoving between the two populations,
providing further support for the notion that companion animals
may act as a reservoir for human MRSA infection and vice versa
(64). This, combined with the findings related to difference in
antibiotic resistance between human and companion animal iso-
lates, highlights the importance of a “one health” view of infec-
tious diseases—that the health of both human and animal popu-
lations are intrinsically linked.
MATERIALS AND METHODS
Isolates. Isolateswere clinical cases submitted to diagnostic laboratories at
the Animal Health Trust and Royal Veterinary Hospital (some isolates
referred via Compton Paddock Laboratories) between August 2003 and
August 2007. The isolates were subjected to in-housemultilocus sequence
typing, and all ST22 isolates were selected to be included for sequencing.
Whole-genome sequencing.Overnight cultureswere grown in tryptic
soy broth (TSB) at 37°C with 200-rpm shaking. Genomic DNA was ex-
tracted from cultures by using the MasterPure Gram-positive DNA puri-
fication kit (Cambio, United Kingdom). Illumina library preparation was
carried out as described byQuail et al. (65) Hi-seq sequencing was carried
out following the manufacturer’s standard protocols (Illumina, Inc.,
United States). Nucleotide sequences of the isolates have been deposited
in the Sequence Read Archive database in the European Nucleotide Ar-
chive (see Table S1 in the supplemental material).
Antibiotic resistance testing.Antimicrobial susceptibility testing was
performed using disk susceptibility testing according to BSAC criteria
(BSACMethods for Antimicrobial Susceptibility Testing, version 11.1, May
2012; British Society for Antimicrobial Chemotherapy, Birmingham,
United Kingdom). NCTC12493 and NCTC6571 were used, respectively,
as control resistant and susceptible isolates for clindamycin.
Phylogenetics and comparative genomics. Fastq files for the isolates
were mapped against the ST22 MRSA reference genome HO 5096 0412
(EMBL accession no.HE681097) using SMALT (http://www.sanger.ac.uk
/resources/software/smalt/) in order to identify single nucleotide poly-
morphisms (SNPs), as previously described (32, 35). SNPs located inmo-
bile genetic elements (MGEs) were identified and removed from the
alignment to generate a core genome (regions of the chromosome not
excluded when MGEs were removed) (see Table S2 in the supplemental
material). A maximum likelihood tree was generated from core genome
SNPs by using RAxML (66). Trees were visualized and annotated with
Figtree (http://tree.bio.ed.ac.uk/software/figtree/) and Interactive TreeOf
Life (67). Comparison of the MGE content and virulence factors of the
isolates was assessed by BLAST analysis against Velvet de novo assemblies
by using MGEs, virulence and antibiotic resistance genes previously re-
ported to be present in the ST22 lineage (32, 68). Comparative genomics
were carried out using Velvet de novo assemblies with contigs realigned
against HO 5096 0412 by Mauve (69) and manually inspected with the
Artemis comparison tool (70).
Randomization tests. To carry out randomization tests of phyloge-
netic clustering, we asked whether the mean evolutionary distance be-
tween members in a specified collection of isolates was significantly
smaller than the mean distance between the same number of randomly
chosen isolates. The reported P values were derived from a null distribu-
tion estimated from 106 random samples of isolates, and all evolutionary
distances were taken from the phylogeny depicted in Fig. 2A.
Time scale of evolution.We used the program BEAST v 1.7.5 (71) to
estimate a dated phylogeny. To scale the rate of evolution, we constrained
the tips of the phylogeny to the date that they were sampled in decimal
years. If the day of the month was unknown, the first of the month was
given as the date, and if the day and month were unknown, 1 June was
used (see Fig. S1 in the supplemental material). Branch rates were drawn
from an uncorrelated log normal distribution with mean rate assigned a
uniformprior on the range 0 to 1.We assumed anHKYmodel of sequence
evolution (72) with a gamma distribution of rate variation among sites.
To model the relative node ages, we assumed either a constant or expo-
nential population size coalescent tree prior. All other priors were as-
signed the defaults as specified in BEAUti v 1.7.5. We ran two separate
Monte CarloMarkov chains (MCMCs) for each tree prior, using themax-
imum likelihood tree as a starting topology, until convergence in all pa-
rameters was reached and the burn-in was10% of the entire run (~3
108 iterations). The maximum clade credibility dated phylogeny (see
Fig. S1) was generated from subsamples of the combined runs with
burn-in removed. Estimates of the first date that ST22 S. aureuswas found
in dogs and cats were taken from the earliest node leading to a dog or cat
isolate, respectively.
Correlated evolution of virulence genes.To test for correlated evolu-
tion between host the isolate was cultured from (human or companion
animal) and virulence gene presence, we used the program BayesTraits
(73), and the posterior sample of trees from our BEAST analysis using a
constant coalescent tree prior. BayesTraits uses a continuous-time
Markov model to estimate transition rates between the presence and ab-
sence of a virulence gene and between human and nonhuman hosts. We
allowed the transition rates to evolve in either a correlated fashion (where
the rate of change in one trait depends on the state found in the other trait)
or independently. Posterior distributions of parameters were estimated
from4 107 iterations of theMCMCwith default priors. After discarding
burn-in, the marginal likelihoods of the dependent and independent
models were obtained using the harmonic mean estimator in Tracer v 1.5
(74) to yield Bayes factors for the competing models.
Regression analysis.We used discriminant analysis of principal com-
ponents (DAPC) in order to identify putative single nucleotide polymor-
phisms (SNPs) with a role in host adaptation (75). DAPC identifies linear
combinations of biallelic SNPs that best discriminate between different
groups (in our case, human, dog, or cat host states). We retained only
SNPswith a1% frequency of theminor allele (a total of 897/6,979 SNPs)
and transformed the data using the dudi.pca function in the R package
ade4, keeping 10 principal components (PCs) for use in the DAPC anal-
ysis (76). In the DAPC analysis using the R package adegenet, we again
retained 10 PCs representing 60% of the total genetic variation and kept
one discriminant function. Visualization of variables that contribute to
between-group discrimination identified five outliers (see Fig. S3 in the
supplemental material). The SNPs are shown in Table S3 in the supple-
mental material. The ancestral state of the SNPs was reconstructed by
mapping the locations of the SNPs back onto the phylogeny.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org
/lookup/suppl/doi:10.1128/mBio.00985-13/-/DCSupplemental.
Figure S1, TIFF file, 6.1 MB.
Figure S2, TIFF file, 0.4 MB.
Figure S3, TIFF file, 0.6 MB.
Table S1, XLSX file, 0.1 MB.
Table S2, XLSX file, 0 1MB.
Table S3, XLSX file, 0 1MB.
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